Two Sigma Investments, LP V Tv Therapeutics Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $225,973 - $327,882	-147,695 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.27 - $3.44 $521,625 - $790,481	-229,791 Reduced 60.87%	147,695 $337,000
Q1 2021 May 17, 2021	BUY	$1.97 - $2.89 $743,647 - $1.09 Million	377,486 New	377,486 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$1.49 - $3.1 $748,719 - $1.56 Million	-502,496 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.7 - $2.98 $67,328 - $118,022	39,605 Added 8.56%	502,496 $889,000

Q2 2020 Aug 14, 2020	BUY	$1.74 - $3.19 $335,117 - $614,381	192,596 Added 71.25%	462,891 $1.04 Million
Q1 2020 May 15, 2020	BUY	$1.63 - $3.75 $296,651 - $682,481	181,995 Added 206.11%	270,295 $516,000
Q4 2019 Feb 14, 2020	BUY	$1.37 - $1.97 $120,971 - $173,951	88,300 New	88,300 $150,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.